APOE and Alzheimer disease: APOE4 genotyping was available in 12 subjects in the Aβ−NC group (all noncarriers), 26 subjects in the Aβ+MCI group (11 noncarriers and 15 carriers), and 10 subjects in the Aβ+AD group (3 noncarriers and 7 carriers).